Shelburne, VT, United States of America

David N Krag

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 1.3

ph-index = 8

Forward Citations = 688(Granted Patents)


Company Filing History:


Years Active: 2000-2007

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: David N Krag: Innovator in Biomedical Research

Introduction

David N Krag, an accomplished inventor based in Shelburne, Vermont, has made significant contributions to the field of biomedical research, particularly in the development of treatments targeting specific disorders. With a robust portfolio of nine patents, Krag's innovations reflect his dedication to improving healthcare through targeted therapies.

Latest Patents

Among his latest patents, one notable innovation is titled "Methods and compositions for inhibiting GRB7." This invention focuses on methods that utilize Grb7 antagonists, which selectively bind to Grb7 and disrupt its interactions with native ligands. Such compositions have the potential to prevent and treat various disorders associated with abnormal Grb7 interactions, such as those involving ErbB2. Another significant patent is "Binding peptides specific for the extracellular domain of ErbB2." This invention presents methods for diagnosing and treating disorders characterized by ErbB2 overexpression, including breast cancer, through the use of specific peptides and peptidomimetics.

Career Highlights

David N Krag has had a distinguished career, contributing to both academia and industry. He has worked with notable institutions including Calypso Medical Technologies, Inc. and the University of Vermont and State Agricultural College. His interdisciplinary approach has played a crucial role in bridging the gap between research and practical medical applications.

Collaborations

Throughout his career, Krag has collaborated with various professionals in the field, including colleagues Stephanie C Pero and Lyn Oligino. These collaborations have further enhanced his research efforts and contributed to the advancement of healthcare innovations.

Conclusion

David N Krag's work exemplifies the critical intersection of innovation and medicine. With his impressive array of patents and a commitment to addressing significant health challenges, Krag continues to be a vital figure in the field of biomedical research, paving the way for future discoveries and advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…